Table 3 Results of in vitro testing for drug-resistance for children TBM in Southwest China, 2013–2018 (n = 42)
Individual drug | No.(%) of isolates with resistant to (n = 42) |
|---|---|
Any drug resistancea | 13 (31.0) |
Any first-line drug resistance | 12 (28.6) |
Any second-line drug resistance | 3 (7.1) |
STR | 4 (9.5) |
INH | 10 (23.8) |
RIF | 3 (7.1) |
EMB | 0 (0.0) |
OFX | 1 (2.4) |
LFX | 0 (0.0) |
AMK | 1 (2.4) |
CM | 0 (0.0) |
PTO | 1(2.4) |
MFX | 1 (2.4) |
RFB | 1 (2.4) |
MDR (INH + RIF) | 2 (4.8) |
pre-XDR | 0 (0.0) |
XDR | 1 (2.4) |
INH + STR | 2 (4.8) |
INH + RIF + STR | 1 (2.4) |
INH + RIF + EMB | 0 (0.0) |
RIF + STR + EMB | 0 (0.0) |
INH + RIF + STR + EMB | 0 (0.0) |